跳轉至內容
Merck
全部照片(1)

重要文件

檢視所有文件

379409

Sigma-Aldrich

1,2-二甲基-3-羟基-4-吡啶酮

98%

同義詞:

去铁酮

登入查看組織和合約定價
全部照片(1)

About This Item

經驗公式（希爾表示法）:
C7H9NO2
CAS號碼:
30652-11-0
分子量：:
139.15
MDL號碼:
MFCD00134497
分類程式碼代碼:
12352100
PubChem物質ID:
24863630
NACRES:
NA.22
暫時無法取得訂價和供貨情況

品質等級

100

化驗

98%

形狀

powder

mp

272-275 °C (lit.)

官能基

ketone

SMILES 字串

CN1C=CC(=O)C(O)=C1C

InChI

1S/C7H9NO2/c1-5-7(10)6(9)3-4-8(5)2/h3-4,10H,1-2H3

InChI 密鑰

TZXKOCQBRNJULO-UHFFFAOYSA-N

尋找類似的產品？ 前往 產品比較指南

相關類別

一般說明

3-羟基-1,2-二甲基-4(1H)-吡啶酮（Hdpp，去铁酮）是一种羟基酮衍生物。 它在酸性水溶液中与铀酰盐[UO2(NO3)2]反应，得到单核复合物（[UO2(dpp)(Hdpp)2(H2O)]ClO4）。 已通过X射线研究分析了这些复合物的结构和几何结构。[1]

應用

3-羟基-1,2-二甲基-4(1H)-吡啶酮（OH-吡啶酮）可用于杀菌试验。[2]它已被用作羟基酮螯合剂，并且已经评估了其对人口腔正常和肿瘤细胞的细胞毒作用。[3]

象形圖

Exclamation mark
GHS07

訊號詞

Warning

危險聲明

H302

防範說明

P301 + P312 + P330

危險分類

Acute Tox. 4 Oral

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 3

閃點（°F）

Not applicable

閃點（°C）

Not applicable

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves

從最近期的版本中選擇一個：

分析證明 (COA)

Lot/Batch Number
STBL1267
STBL1268
STBK5488
STBJ7316
STBJ3298

未看到正確版本？

如果您需要一個特定的版本，您可以透過批號來尋找特定憑證。

搜尋 COA

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Chryssoula Drouza et al.
Inorganic chemistry, 43(26), 8336-8345 (2004-12-21)
Reaction of [UO(2)(NO(3))(2)] with the hydroxy ketones 3-hydroxy-2-methyl-4-pyrone (Hma) and 3-hydroxy-1,2-dimethyl-4(1H)-pyridone (Hdpp) in aqueous acidic solutions (pH approximately 3) yields the compounds [UO(2)(ma)(2)(H(2)O)].H(2)O (1.H(2)O) and [UO(2)(dpp)(Hdpp)(2)(H(2)O)]ClO(4) (2), respectively. X-ray diffraction shows that the geometry around the metal ion in both
Etheresia Pretorius et al.
Toxicology mechanisms and methods, 23(5), 352-359 (2013-01-03)
Inflammatory diseases associated with iron overload are characterized by a changed coagulation profile, where there is a persistent presence of fibrin-like material of dense-matted deposits (DMDs). It is believed that one source of such material is a result of the
Jaroslav Cermak et al.
Leukemia research, 37(12), 1612-1615 (2013-08-14)
One hundred thirteen patients with myelodysplastic syndromes (MDS) with <10% of bone marrow blasts received either deferiprone in a daily dose of 40-90 mg/kg (48 patients) or deferasirox in a daily dose of 10-40 mg/kg (65 patients). Median duration of
Carole Peyssonnaux et al.
The Journal of clinical investigation, 115(7), 1806-1815 (2005-07-12)
Hypoxia is a characteristic feature of the tissue microenvironment during bacterial infection. Here we report on our use of conditional gene targeting to examine the contribution of hypoxia-inducible factor 1, alpha subunit (HIF-1alpha) to myeloid cell innate immune function. HIF-1alpha
Eiji Yasumoto et al.
Anticancer research, 24(2B), 755-762 (2004-05-27)
Hydroxyketone chelators, deferiprone (HK1), maltol (HK3) and their related compounds (HK2, 4-8), were characterized for their cytotoxic profiles against oral human normal and tumor cells. Most hydroxyketones except HK6 showed relatively higher tumor-specific cytotoxicity. Deferiprone (HK1), which showed the highest
查看所有相關論文

Questions

1–2 of 2 Questions  

  1. What is the suggested solvent and what is the solubility of Deferiprone? Can Deferiprone solution be stored and at which temperature?

    1 answer

    1. This product is soluble in methanol at 5mg/ml. It is not recommended to store aqueous solutions. It is recommended to use freshly prepared solutions.

      Helpful?

  2. What is the recommended storage temperature?

    1 answer

    1. This product is stored at room temperature.

      Helpful?

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務